The 4th Mayo – Sheba Cardiovascular Symposium25th March 2018

Sheba Medical Center

p

Symposium‏Cardiac‏Sheba‏Mayo‏nd‏2‏Approach‏Based‏Case‏–‏Cardiology‏in‏Frontiers‏New‏

Sunday‏December9‏th‏‏,‏Heart‏Center‏Auditorium

09:00 – 09:30 Welcome‏and‏opening‏remarks‏and‏review‏of‏the‏collaborative‏project ‏ Zeev‏Rotstein‏ Michael‏Eldar‏‏ Michael‏Glikson‏ Amir‏Lerman‏09:30 – 11:00 Session‏I‏‏‏Case‏Based‏‏Clinical‏Updates The pericardium – no more Terra Incognita for the electrophysiologist Sam‏Asirvatham‏ Acute coronary syndrome in women : case based approach Amir‏Lerman Update on Cardiac Rehabilitation – The gold standard for CVD secondary prevention therapy? Randall‏Thomas11:00 - 11:30 Coffee Break 11:30 – 12:30 Session‏II‏Clinical‏and‏basic‏‏Updates Bone marrow-based cell therapy for CV disease. Robert‏Simari Assessment of severity of aortic stenosis Jae‏K‏Oh12:30-14:00 Session‏III‏-‏Collaborative‏research‏update The raise CRT trial Michael‏Glikson New echo parameter for CRT Jae‏K‏Oh Endothelial dysfunction in clinical practice Amir‏Lerman Resident vascular progenitor cells. Robert‏Simari Exercise training in AF patients Randall‏Thomas 14:00 – 15:00 Lunch Buffet 15:00 – 16:30 Business‏meeting‏of‏research‏groups 17:00 Reception 18:30 Adjournment

required‏registration‏Advance‏marketing@sheba.health.gov.il‏:email,‏www.sheba.co.il‏:Registration‏

09:00 – 09:30 Welcome‏and‏opening‏remarks‏and‏review‏of‏the‏collaborative‏project ‏ Zeev‏Rotstein‏ Michael‏Eldar‏‏ Michael‏Glikson‏ Amir‏Lerman‏09:30 – 11:00 Session‏I‏‏‏Case‏Based‏‏Clinical‏Updates The pericardium – no more Terra Incognita for the electrophysiologist Paul‏Friedman‏ Acute coronary syndrome in women : case based approach Amir‏Lerman Update on Cardiac Rehabilitation – The gold standard for CVD secondary prevention therapy? Randall‏Thomas11:00 - 11:30 Coffee Break 11:30 – 12:30 Session‏II‏Clinical‏and‏basic‏‏Updates Bone marrow-based cell therapy for CV disease. Robert‏Simari Assessment of severity of aortic stenosis Jae‏K‏Oh12:30-14:00 Session‏III‏-‏Collaborative‏research‏update The raise CRT trial Michael‏Glikson New echo parameter for CRT Jae‏K‏Oh Endothelial dysfunction in clinical practice Amir‏Lerman Resident vascular progenitor cells. Robert‏Simari Exercise training in AF patients Randall‏Thomas 14:00 – 15:00 Lunch Buffet

required‏registration‏Advance‏marketing@sheba.health.gov.il‏:email,‏www.sheba.co.il‏:Registration‏

The C

haim

She

ba M

edical Center at Tel Hashomer l Est. 1948

The Hospital of Israel

Mackram Eleid - Structural and Ischemic Heart Disease

Steve Ommen - Hypertrophic Cardiomyopathy

Kyle Klarych - Hypertrophic Cardiomyopathy

Amir Lerman - Coronary Physiology

Paul Friedman - Electrophysiology

Hartzell Schaff – CV Surgery

Sudhir Kushwaha - Cardiac Transplant/Heart Failure

Rihal S. Charanjit - Chair, Division of Cardiovascular Diseases

8:00 – 8:30 Registration and coffee

8:30 – 8:45 Welcome (Kreiss, Raanani, Segev,

Glikson)

8:45 – 9:00 Brief review of the Mayo Sheba

Collaboration (Glikson + Lerman)

9:00 - 9:30 Progress report of three

Collaborative Mayo – Sheba

studies (Glikson , Shechter , Leor)

9:30 - 11:00 Session I – HCMP overview

9:30 – 9:35 Welcome by Dr Daniel Monakier,

Chair, Israeli Heart Society

Cardiomyopathy working group

9:35 – 9:55 Variants and differential diagnosis

of HCMP (Klarych)

9:55 - 10:15 The role of genetic testing in

HCMP (Arad)

10:15-10:35 Noise & Order: Maintenance and

growth of cardiac sarcomeres

(Kehat)

10:35-10:55 Understanding HCMP and current

knowledge gaps (Ommen)

10:55-11:15 Coronary pathophysiology in

HOCM (Lerman)

11:15-11:30 Q&A

11:30-12:00 Coffee break

12:00–13:30 Session II - Treatment of HCMP

12:00–12:15 Treatment according to ESC

and ACC guidelines for HCMP

– similarities and differences

(Ommen)

12:15-12:30 Surgical treatment of HOCM in 2017

– an overview (Schaff)

12:30-12:45 Catheter based septal ablation –

an overview (Eleid)

12:45-13:00 Septal Myectomy, Sheba

experience- (Raanani)

13:00-13:15 What is the risk of SCD following

septal ablation and following

myectomy? (Friedman)

13:15-13:30 Septal ablation vs myectomy –

Case – based discussion:

Moderator: Ommen

Discussants: Schaff, Eleid

13:30-14:30 Lunch

14:30-16:00 Session III

14:30-14:50 Current role of imaging in HCMP

(Klarych)

14:50-15:10 Risk stratification and prevention

of sudden death in HCMP

(Friedman)

15:10-15:30 Systolic and diastolic heart failure

in HCMP (Kushwaha)

15:30-15:50 The mitral valve in HCMP –

mechanism and evaluation

(Kuperstein)

15:50-16:00 Q&A

Sunday March 25th 2018

Please be advised that due to limited seating in the auditoriumregistration is required.

Contact for registration:Marketing department, Sheba Medical Center

E-mail: marketing@sheba.health.gov.ilTel: +972-3-5305000, choose line 0 and then line 2, 8:00-16:00

ENTRANCE IS FREE